pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,487
stories
12h
Eli Lilly and the LA Dodgers: A tale of 2 dynasties
biospace
12h
Merck barred from making subcutaneous Keytruda in 8 European countries
biospace
15h
STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis
stat
16h
STAT+: Roche goes beyond licensing in deal with Chinese biotech
stat
19h
STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
stat
19h
The Nobel boys club (again)
stat
19h
Caribou to stop R&D work, start ‘substantial’ job cuts
biospace
22h
AI biotech Iambic aims for $135M IPO to push cancer drugs through clinic
fiercebiotech
22h
Breast cancer can behave differently in older women. This physician is making more tailored treatments a reality
stat
22h
STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients
stat
22h
Opinion: England and other nations are on the path toward eliminating hepatitis C. Why not the U.S.?
stat
22h
Opinion: How CMS plans to fix a major flaw in the 340B drug discount program
stat
1d
Ono pays $80M for regional rights to trio of Biohaven IgG degraders, including phase 3 Grave’s asset
fiercebiotech
1d
Q3 layoffs down YOY, with 90% fewer biopharma employees affected
biospace
1d
Dutch court blocks subcutaneous Keytruda in eight European countries
endpoints
1d
Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate
biopharma dive
1d
Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial
biopharma dive
1d
STAT+: Merck suffers a setback in Europe over its new Keytruda formulation
stat
1d
ArriVent sheds nearly half of value on late-stage lung cancer miss
biospace
1d
Biotech VC Forbion raises record $2.6B to support 30 ‘high-potential’ companies
biospace
1d
Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes up
biospace
1d
MimiVax's cancer vaccine for glioblastoma narrowly misses Phase 2b goal
endpoints
1d
ER visits from people born outside the U.S. dropped after ICE raids
stat
1d
ARPA-H unveils Surpass program to accelerate and expand clinical trials
fiercebiotech
1d
Bayer commits $2.2B to build pharma manufacturing plant in Ohio
biospace
1d
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
biospace
1d
Opinion: My oncologist recommended active surveillance for prostate cancer. Life insurers called it ‘untreated cancer’
stat
1d
STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
stat
1d
Matchpoint nets $150M series B to take covalent med into clinic
fiercebiotech
2d
5 biggest venture capital raises of Q3 2026
biospace
← prev
page 1 of 50
next →
